A2 Biotherapeutics IPO

A2 Biotherapeutics is a precision therapy platform with a focus on solid cancers and tumors.

Register for Details

For more details on financing and valuation for A2 Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is A2 Biotherapeutics's ticker symbol?

A2 Biotherapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is A2 Biotherapeutics's stock price?

The stock price for A2 Biotherapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

A2 Biotherapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/4/2022 Series B $143.13MM raised $XXX.XX $XXX.XX
11/5/2019 Series A and A-1 $64.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about A2 Biotherapeutics

Forge green plus iconForge green minus icon

What is A2 Biotherapeutics funding to date?

A2 Biotherapeutics has raised $207.63MM to date.
Forge green plus iconForge green minus icon

When was A2 Biotherapeutics founded?

A2 Biotherapeutics was founded in 2017.
Forge green plus iconForge green minus icon

Can you invest in A2 Biotherapeutics?

A2 Biotherapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell A2 Biotherapeutics share pre-IPO?

If you own A2 Biotherapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is A2 Biotherapeutics a publicly traded company?

A2 Biotherapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like A2 Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$500MM
Updated on: Dec 6, 2022